[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338653-105":59,"doc-detail-338653-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","silencing-of-epidermal-growth-factor-like-domain-8-promotes-proliferation-and-cancer-aggressiveness-in-human-ovarian-cancer-cells-full-text-article-summary","Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells - Full text article summary","","Ovarian cancer is a highly lethal female reproductive cancer marked by drug resistance, metastasis, and poor prognosis. This study evaluates the function of epidermal growth factor-like domain 8 (EGFL8) in human ovarian cancer using siRNA-mediated EGFL8 knockdown. EGFL8 silencing promotes proliferation, colony formation, migration, invasion, chemoresistance, and decreases apoptosis. It also increases EMT markers and cancer stem cell biomarkers, elevates MMP-2/MMP-9 and drug-resistance genes, and correlates low EGFL8 with worse outcomes, indicating ERK/MAPK pathway suppression as the key mechanism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/silencing-of-epidermal-growth-factor-like-domain-8-promotes-proliferation-and-cancer-aggressiveness-in-human-ovarian-cancer-cells-full-text-article-summary/338653/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/silencing-of-epidermal-growth-factor-like-domain-8-promotes-proliferation-and-cancer-aggressiveness-in-human-ovarian-cancer-cells-full-text-article-summary/338653.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study on EGFL8 in ovarian cancer?","Question",{"text":112,"@type":113},"To determine how epidermal growth factor-like domain 8 (EGFL8) affects human ovarian cancer progression by examining siRNA-mediated EGFL8 knockdown effects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cellular behaviors changed after EGFL8 knockdown?",{"text":117,"@type":113},"EGFL8 knockdown promoted aggressive traits including enhanced proliferation, colony formation, migration, invasion, and chemoresistance, while reducing apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"How did EGFL8 silencing influence molecular pathways and biomarkers?",{"text":121,"@type":113},"EGFL8 knockdown upregulated EMT markers and cancer stem cell biomarkers, increased MMP-2/MMP-9 and drug-resistance genes, and suppressed ERK/MAPK signaling, which is linked to reduced cancer aggressiveness.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338653,1790127700,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \nSilencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells by Activating ERK/MAPK Signaling Cascades  \nYong-Jung Song 1,2,†, Ji-Eun Kim 3,†, Lata Rajbongshi 3, Ye-Seon Lim 3, Ye-Jin Ok 3, Seon-Yeong Hwang 3,  \nHye-Yun Park 3, Jin-Eui Lee 3, Sae-Ock Oh 3, Byoung-Soo Kim 4, Dongjun Lee 5, Hwi-Gon Kim 1,2 and Sik Yoon 2,3,*  \nAcademic Editor: Antonino Germana  \nReceived: 22 November 2024  \nRevised: 24 December 2024  \nAccepted: 29 December 2024  \nPublished: 31 December 2024  \nCitation: Song, Y.-J.; Kim, J.-E.; Rajbongshi, L.; Lim, Y.-S.; Ok, Y.-J.; Hwang, S.-Y.; Park, H.-Y.; Lee, J.-E.; Oh, S.-O.; Kim, B.-S.; et al. Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness inHuman Ovarian Cancer Cells by Activating  \nERK/MAPK Signaling Cascades. Int.  \nJ. Mol. Sci. 2025, 26, 274. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26010274](doi.org/10.3390/ijms26010274)  \n[Copyright:](Copyright:) © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital and Pusan National University College of Medicine, Yangsan 50612, Republic of Korea; [gynsong@gmail.com](gynsong@gmail.com) (Y.-J.S.); [bislsan@naver.com](bislsan@naver.com) (H.-G.K.)  \n2 Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea  \n3 Department of Anatomy and Convergence Medical Sciences, Pusan National University College of Medicine, Yangsan 50612, Republic of Korea; [ji.eun@pusan.ac.kr](ji.eun@pusan.ac.kr) (J.-E.K.); [latapharm@gmail.com](latapharm@gmail.com) (L.R.); [yeseonlim@pusan.ac.kr](yeseonlim@pusan.ac.kr) (Y.-S.L.); [yj0429@pusan.ac.kr](yj0429@pusan.ac.kr) (Y.-J.O.); [anatomy2017@pusan.ac.kr](anatomy2017@pusan.ac.kr) (S.-Y.H.); [qkrvlfg123@naver.com](qkrvlfg123@naver.com) (H.-Y.P.); [wlsdbs88@naver.com](wlsdbs88@naver.com) (J.-E.L.)  \n4 School of Biomedical Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea; [bskim7@pusan.ac.kr](bskim7@pusan.ac.kr)  \n5 Department of Convergence Medicine, Pusan National University College of Medicine, Yangsan 50612, Republic of Korea; [lee.dongjun@pusan.ac.kr](lee.dongjun@pusan.ac.kr)  \n* Correspondence: [sikyoon@pusan.ac.kr](sikyoon@pusan.ac.kr); Tel.: +82-51-5108044; Fax: +82-51-5108049 † These authors contributed equally to this work.  \nAbstract: Ovarian cancer (OC) is the second most common female reproductive cancer and the most lethal gynecological malignancy worldwide. Most human OCs are characterized by high rates of drug resistance and metastasis, leading to poor prognosis. Improving the outcomes of patients with relapsed and treatment-resistant OC remains a challenge. This study aimed to investigate the role of epidermal growth factor-like domain 8 (EGFL8) inhuman OC by examining the effects of siRNA-mediated EGFL8 knockdown on cancer progression. EGFL8 knockdown in human OC cells promoted aggressive traits associated with cancer progression, including enhanced proliferation, colony formation, migration, invasion, chemoresistance, and reduced apoptosis. Additionally, knockdown upregulated the expression of epithelial–mesenchymal transition (EMT) markers (Snail, Twist1, Zeb1, Zeb2, and vimentin) and cancer stem cell biomarkers (Oct4, Sox2, Nanog, KLF4, and ALDH1A1), and increased the expression of matrix metallopeptidases (MMP-2 and MMP-9), drug resistance genes (MDR1 and MRP1), and Notch1 . Low EGFL8 expression also correlated with poor prognosis in human OC. Overall, this study provides crucial evidence that EGFL8 inh","cbCaij3uS8IPO2Zp","https://ap.wps.com/l/cbCaij3uS8IPO2Zp","pdf",8261748,33,"English","# Introduction\n# Abstract\n## Methods focus (siRNA knockdown)\n## Key outcomes (proliferation, EMT, chemoresistance)\n# Keywords","[{\"question\":\"What was the main goal of the study on EGFL8 in ovarian cancer?\",\"answer\":\"To determine how epidermal growth factor-like domain 8 (EGFL8) affects human ovarian cancer progression by examining siRNA-mediated EGFL8 knockdown effects.\"},{\"question\":\"What cellular behaviors changed after EGFL8 knockdown?\",\"answer\":\"EGFL8 knockdown promoted aggressive traits including enhanced proliferation, colony formation, migration, invasion, and chemoresistance, while reducing apoptosis.\"},{\"question\":\"How did EGFL8 silencing influence molecular pathways and biomarkers?\",\"answer\":\"EGFL8 knockdown upregulated EMT markers and cancer stem cell biomarkers, increased MMP-2/MMP-9 and drug-resistance genes, and suppressed ERK/MAPK signaling, which is linked to reduced cancer aggressiveness.\"}]","Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells - Full text article summary | PDF",1790024844,83,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/960f3388e4b5ec832c64a986c6c9ffd5.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/bd7439900c93951c3bce7d4bb1480e5f.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/a024f9d37455edf45ab81bfe00d79f4a.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/bec01d7ed99dc8d5f1cf417e9e729b6b.webp",980,1385]